Recursion and Exscientia Merge to Lead AI Drug Discovery

Excited to share that Recursion and portfolio company Exscientia have agreed to merge!

This merger brings together Exscientia’s generative AI chemistry platform with Recursion’s high throughput target discovery capabilities to create the clear leader in AI drug discovery.

Congrats to long-time friends on both teams!

https://lnkd.in/gnZsYwXd